Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and
limitations
Publication in policy or professional journal


引用次數
替代計量分析
.

其它資訊
摘要Pre-treatment or early intra-treatment prediction of patients with head and neck squamous cell carcinomas (HNSCC) who are likely to have tumours that are resistant to chemoradiotherapy (CRT) would enable treatment regimens to be changed at an early time point, or allow patients at risk of residual disease to be targeted for more intensive post-treatment investigation. Research into the potential advantages of using functional-based magnetic resonance imaging (MRI) sequences before or during cancer treatments to predict treatment response has been ongoing for several years. In regard to HNSCC, the reported results from functional MRI research are promising but they have yet to be transferred to the clinical domain. This article will review the functional MRI literature in HNSCC to determine the current status of the research and try to identify areas that are close to application in clinical practice. This review will focus on diffusion-weighted imaging (DWI) and dynamic contrast-enhanced MRI (DCE–MRI) and briefly include proton magnetic resonance spectroscopy (1H-MRS)and blood oxygen level dependent (BOLD) MRI.
著者King, Ann D, Thoeny, Harriet C
期刊名稱Cancer Imaging
出版年份2016
月份8
卷號16
期次23
出版社BioMed Central
國際標準期刊號1740-5025
語言英式英語
關鍵詞Cancer, Chemotherapy, DCE, DWI, Head and neck, MRI, MRS, Radiotherapy, Response, Squamous cell carcinoma

上次更新時間 2021-16-09 於 01:28